Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16).

CONCLUSIONS: This study suggests the benefit of tumor bed boost might be minimal in ypCR patients following NAC and BCT. Larger prospective studies are needed to address this issue. PMID: 30844692 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30844692?dopt=Abstract

Source: Breast - February 25, 2019 Category: Cancer & Oncology Authors: Cho WK, Park W, Choi DH, Kim YB, Suh CO, Shin KH, Chie EK, Kim JH, Ahn SD, Kim SS, Kim K, Kim JH, Ahn SJ, Lee SY, Lee J, Kim SW, Kwon J, Ahn KJ, Shin HS, Lee HS, Lee NK Tags: Breast Source Type: research